Citations

Clear

64 citation(s) found for "Bax, J J B".

Sex Differences in Clinical Presentation and Outcome of Degenerative Mitral Regurgitation Quantified: The MIDA-Q Registry
Essayagh, Benjamin , Benfari, Giovanni , Butcher, Steele C , Tsaban, Gal , Grigioni, Francesco , Le Tourneau, Thierry , Bax, Jeroen J , Marsan, Nina Ajmone , Tribouilloy, Christophe , Topilsky, Yan , Thapa, Prabin , Michelena, Hector I , Enriquez-Sarano, Maurice

Mayo Clinic

Circulation: Cardiovascular Imaging | September 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circimaging.125.019952 | PMID 42813276 Get It

BACKGROUND: Degenerative mitral regurgitation (DMR) due to valve prolapse predominates in men, but sex-specific differences are poorly understood due to a lack of quantitative and sex-stratified studies. METHODS: The international MIDA-Q (Mitral Regurgitation International Database-Quantitative) registry enrolled 3274 men and 2331 women with greater than or equal to mild DMR prospectively quantified, comprehensively characterized, and long-term follow-up. RESULTS: Women were more symptomatic despite lower effective regurgitant orifice (ERO, 27±18 versus 38±22 mm 2 , standardized mean difference 0.54; P <0.0001) and regurgitant volume (46±26 versus 61±31 mL/beat, standardized mean difference 0.52; P <0.0001), even for similar mitral lesions. With increasing ERO, women showed lower regurgitant volume, higher heart rate, lower blood pressure, but left ventricular size response in women was smaller in absolute measures while larger when body surface area normalized, with higher ejection fraction and cardiac index (all P <0.0001). Incidence of mitral valve surgery was similar in symptomatic women and men, but lower in asymptomatic women versus men (adjusted hazard ratio, 0.80 [0.69–0.94]; P =0.008) for similar ERO, linked to smaller left ventricular diastolic absolute diameter ( P <0.0001). Excess mortality under medical management (of severe versus mild ERO) was similar in women (adjusted hazard ratio, 1.67 [1.24–2.24]; P =0.0007) and men (adjusted hazard ratio, 1.63 [1.27–2.09]; P <0.0001) and versus expected survival (2.12 [1.51–2.98] in women and 2.27 [1.75–2.94] in men). However, moderate ERO (20–39 mm 2 ) was associated with significant excess mortality in women (1.47 [1.19–1.77] versus mild). In men, the corresponding hazard ratio did not reach statistical significance. Postoperative survival was similar in men and women. CONCLUSIONS: Women with DMR present with lower ERO and regurgitant volume than men and with considerable adaptive differences to increasing DMR severity versus men. Asymptomatic women are less referred to surgery than men of similar DMR severity, linked to smaller absolute left ventricular size. Severe DMR by similar quantitative thresholds causes similar excess mortality in men and women; moderate quantitative DMR shows a trend for higher excess mortality versus expected in women than men, requiring further confirmation. These data emphasize the importance of quantitative DMR and left ventricular remodeling assessment in men and women for appropriate clinical management.
Comparable Outcomes and Implant Survivorship of Total Knee Arthroplasty After High Tibial Osteotomy and Primary Arthroplasty
Bax, Eva , Ahmad, Rana A. , Clark, Sean C. , Custers, Roel J.H. , Taunton, Michael J., Sierra, Rafael J. , Saris, Daniël B.F. , Hevesi, Mario , Bax, Eva A , Sierra, Rafael J , Hevesi, Mario , Custers, Roel J.H. , Taunton, Michael J. , Saris, Daniël B.F.

Mayo Clinic

JBJS Open Access | May 6, 2026 | Volume: 11 | Issue: 2 | Pages: No page available

10.2106/jbjs.oa.25.00303 | PMID 42095123 Get It

Background: Total knee arthroplasty (TKA) is the treatment of choice for end-stage knee osteoarthritis in many patients. In younger patients with predominantly medial compartment disease, high tibial osteotomy (HTO) is performed as a joint-preserving treatment. However, concerns remain regarding potentially compromised outcomes of TKA after previous HTO given the axial deviation, osteotomy site, secondary surgery, previous hardware, and instrumentation. Therefore, this study compared long-term implant survival, revision, and infection rates, and patient-reported outcomes between patients undergoing TKA after HTO and matched TKA-only controls. Methods: Postoperative complications and revision surgeries were prospectively recorded in patients who underwent TKA from 2000 to 2023 at a single academic center. Patients with previous ipsilateral HTO formed the study group and were propensity matched 1:2 to TKA-only patients without a previous osteotomy based on age, sex, and body mass index. Knee Society Scores (KSS) were collected prospectively. Implant survivorship was analyzed using Kaplan-Meier survival curves and Cox proportional hazards models. Results: The study included 134 HTO-TKA and 268 matched TKA-only patients, with a mean follow-up of 10.5 ± 6.4 years (range: 0-24 years) after TKA. Both groups showed significant postoperative improvements in KSS (p < 0.02) with comparable clinical outcomes (HTO-TKA: 79.0 (6.0), TKA-only: 79.0 (11.8)). Revision arthroplasty rates were 5.2% for HTO-TKA and 4.5% for TKA-only (p = 0.69); the mean time to revision was 8.1 ± 8.7 years vs. 4.4 ± 3.5 years, respectively (p = 0.30). Infection rates were 2.2% and 1.1%, respectively (p = 0.74). Conclusions: Revision and infection rates were comparable between HTO-TKA and matched TKA-only patients, with no statistically significant differences. Our findings demonstrate comparable patient-reported outcomes in both groups. These findings indicate that a previous HTO does not adversely affect TKA implant longevity or clinical outcomes when compared with matched primary TKA patients within the US population. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Extent and Progression of Cardiac Damage in Patients With Primary Mitral Regurgitation Undergoing Surgical Repair
Myagmardorj, Rinchyenkhand , Fortuni, Federico , Mantegazza, Valentina , Wijngaarden, A.K.S. van, Wu, Hoi Wai , Palmen, Meindert , Pepi, Mauro, Fusini, Laura , Muratori, Manuela , Essayagh, Benjamin , Tribouilloy, Christophe​, Tourneau, Thierry Le, Bohbot, Y, Michelena, Hector I, Bax, Jeroen J, Marsan, Nina Ajmone, Fortuni, Federico , Wijngaarden, Aniek L. van , van Wijngaarden, Aniek , Pepi, Mauro , Tribouilloy, Christophe , Le Tourneau, Thierry , Bohbot, Yohann , Michelena, Hector I , Enriquez-Sarano, Maurice , Bax, Jeroen J , Marsan, Nina Ajmone , Essayagh, Benjamin , Tribouilloy, Christophe , Tourneau, Thierry Le , Bohbot, Yohann , Michelena, Héctor I. , Enriquez‐Sarano, Maurice , Bax, Jeroen J. , Marsan, Nina Ajmone

Mayo Clinic

European Journal of Cardio-Thoracic Surgery | April 9, 2026 | Volume: 68 | Issue: 5 | Pages: No page available

10.1093/ejcts/ezag149 | PMID 41967857 Get It

Abstract Objectives The progression of extra-mitral valve (MV) cardiac damage in patients with primary mitral regurgitation (MR) following surgical repair has not been described. We aimed to investigate the evolution of extra-MV cardiac damage after MV repair and to assess its prognostic significance. Methods Patients with severe primary MR undergoing surgical repair at 5 referral centres were included when echocardiographic follow-up assessment was available. Based on echocardiographic parameters at baseline and at a median follow-up of 7 (interquartile range [IQR] 4-11) months after MV repair, patients were hierarchically classified as follows: stage 0: no cardiac damage; stage 1: left ventricular dilatation and/or dysfunction; stage 2: left atrial dilatation and/or atrial fibrillation; stage 3: pulmonary hypertension and/or significant tricuspid regurgitation. The primary outcome was all-cause mortality. Results A total of 764 patients (mean age 62 ± 13 years, 70% men) were included. Compared to baseline, 43% improved at least 1 stage, 49% remained unchanged, and 8% worsened at least 1 stage during follow-up after MV repair. At a median follow-up of 91 months after MV repair, 94 patients (12%) died. By multivariate Cox regression analysis, after adjusting for potential confounders, extra-MV cardiac damage staging at follow-up (HR per-1-stage-increase = 1.571; P = .009) and cardiac damage evolution (improved group, HR = 0.467; P = .034; worsened group, HR = 2.481, P = .037) were independently associated with all-cause mortality and had incremental prognostic value over preprocedural assessment. Conclusions Extra-MV cardiac damage improves significantly after MV repair, and its evolution is independently associated with all-cause mortality, suggesting the importance of comparative echocardiographic assessment following MV repair to improve risk stratification.
Left ventricular ejection fraction and benefit of tricuspid valve interventions: Insights from the international TRIGISTRY
Heitzinger, Gregor, Dreyfus, J, Topilsky, Y, Bonis, M De, Carnero-Alcazar, M, Rudolph, V, Crestanello, J, Lurz, P H I L I P, Bax, J J, Maisano, F, Enriquez-Sarano, M, Bartko, P E, Messika-Zeitoun, D, Heitzinger, Gregor , Dreyfus, Julien , Dannenberg, Varius , Topilsky, Yan , Taramasso, Maurizio , Bonis, Michele De , Carnero, Manuel , Crestanello, Juan A. , Bax, J J B, Maisano, Francesco , Enriquez‐Sarano, Maurice , Bartko, P E, Messika–Zeitoun, David

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.2363 Get It

Abstract Background The impact of treatment for tricuspid regurgitation (TR) across different levels of left ventricular ejection fraction (LVEF) remains uncertain. Purpose This study aimed to compare the outcomes of surgical and transcatheter tricuspid valve interventions (TTVI) to conservative (medical) management across all LVEF categories. Methods Patients with severe isolated TR from the TRIGISTRY, a multicenter international registry, were categorized based on LVEF (preserved EF-pEF:≥50%, mildly reduced EF-mrEF:41–49%, and reduced EF-rEF:≤40%). We assessed the impact of treatment modality and procedural success, defined as residual TR ≤mild-to-moderate, on two-year survival within each LVEF category. Results Among 2,384 patients, 1,383 had pEF, 400 had mrEF, and 601 had rEF. Compared to conservative management, surgery (P&lt;0.0005) and TTVI (P&lt;0.0001) were associated with a survival benefit in patients with pEF. No significant survival advantage was observed in patients with mrEF (P=0.28 for both), nor in those with rEF (P=0.76 and P=0.22 respectively). Similar results were obtained when surgical and transcatheter interventions were grouped together (P&lt;0.0001, P=0.17 and P=0.29 in patients with pEF, mrEF and rEF respectively). Patients with significant residual TR after TTVI exhibited a trend toward worse survival compared to those managed conservatively across all LVEF categories (P=0.47, P=0.33, and P=0.008 respectively)(Figure 1). Conclusion Tricuspid valve intervention, whether surgical or transcatheter-based, was associated with improved survival in patients with preserved LVEF but not in those with mildly reduced or reduced LVEF. Residual TR remained a significant prognostic factor across the entire LVEF spectrum. These findings highlight the need for careful patient selection when considering tricuspid interventions in individuals with reduced LVEF.Figure 1
Benefits of tricuspid valve intervention on outcomes based on underlying etiology in patients with severe functional tricuspid regurgitation: insights from the international TRIGISTRY
Iliadis, C, Dreyfus, J, Topilsky, Y, Bonis, M De, Carnero-Alcazar, M, Rudolph, V, Crestanello, J., Lurz, P H I L I P, Bartko, P E, Bax, J J, Enriquez-Sarano, M, Pfister, R, Messika-Zeitoun, D, Iliadis, Christos , Dreyfus, Julien , Topilsky, Yan , Taramasso, Maurizio , Bonis, Michele De , Carnero, Manuel , Bartko, P E, Bax, J J B, Maisano, Francesco , Enriquez‐Sarano, Maurice , Messika–Zeitoun, David

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.2376 Get It

Abstract Background While tricuspid regurgitation (TR) is predominantly functional, it can arise from various cardiac conditions. This study aimed to evaluate whether the benefits of tricuspid valve intervention, compared to conservative management, differ based on the underlying etiology. Methods In the TRIGISTRY international cohort, which includes consecutive patients with severe isolated functional TR across 33 centers in 10 countries, we compared mortality rates at 2 years between patients who underwent a tricuspid valve intervention (surgical or transcatheter) versus conservative management according to TR etiology. Patients were classified into three groups: (1) Isolated TR (ITR), defined as left ventricular ejection fraction (LVEF) &gt;60%, systolic pulmonary artery pressure (sPAP) &lt;50 mmHg, and no prior left-heart intervention (LHI); (2) LHI-TR, comprising patients with a history of LHI; and (3) Undetermined TR (UTR), which included those who did not meet the criteria for ITR or LHI, as well as those with missing sPAP data. Given previous findings indicating that intervention provided no survival benefit for patients with a high TRI-SCORE, the present analysis was restricted to individuals with low to intermediate TRI-SCORE (≤5). Survival outcomes between groups were compared using restricted mean survival time (RMST). Results A total of 1,552 patients (72±13 years; 56% female) with severe functional TR and a low (48%) or intermediate (52%) TRI-SCORE were included. Of these, 772 (50%) underwent an intervention, while 780 (50%) were conservatively managed. TR was classified as ITR in 201 patients (13%), LHI in 395 (25%), and UTR in 956 (62%). Overall, patients with ITR exhibited the lowest comorbidity burden, whereas those with UTR had the highest. After adjusting for comorbidities and TRI-SCORE, a survival benefit of a tricuspid valve intervention was observed in patients with ITR (survival estimate: 0.17, 95% CI [0.009, 0.32], P=0.039) and, to a lesser extent, in patients with UTR (survival estimate: 0.09, 95% CI [0.0, 0.184], P=0.048), but not in those with prior LHI (survival estimate: 0.06, 95% CI [-0.08, 0.2], P=0.4). Similar results were found when excluding patients with moderate or greater residual TR after intervention. Conclusion In TRIGISTRY, patients with ITR appeared to derive the greatest benefit from tricuspid valve intervention, followed to a lesser extent by those with UTR, while no benefit was observed in patients with prior LHI. However, the potential influence of unaccounted confounders cannot be excluded, and further studies are needed to better identify patients’ subsets that may derive the most benefit from a tricuspid valve intervention.
Left ventricular remodelling patterns in patients with primary mitral regurgitation
Elmasry, N , Myagmardorj, R, Santi, P Lopez, Wu, H W, Palmen, M, Essayagh, B, Michelena, H, Enriquez-Sarano, M, Bax, J J B, Marsan, N A M Ajmone, Myagmardorj, Rinchyenkhand , He, J, Santi, Pilar López , Wu, H W , Palmen, Meindert , Essayagh, Benjamin , Michelena, Héctor I. , Enriquez‐Sarano, Maurice , Marsan, Nina Ajmone

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | January 30, 2026 | Volume: 27 | Issue: Supplement_1 | Pages: No page available

10.1093/ehjci/jeaf367.199 Get It

Abstract Background Left ventricular (LV) remodeling in patients with valvular heart disease may vary according to the type of overload (pressure vs volume) as well as patients’ characteristics and comorbidities. Different LV remodeling patterns can be defined based on either an increase in LV mass index (LVMI), relative wall thickness (RWT), or both, and have been largely studied in patients with aortic valve disease but not in patients with primary mitral regurgitation (PMR). Purpose To describe the prevalence and baseline characteristics of the different LV remodeling patterns in PMR patients undergoing mitral valve (MV) surgery, and their association with outcome. Methods Four LV remodeling patterns were identified before MV surgery according to LVMI and RWT (Fig1-a). A cutoff of &gt;115 g/m2 in males or &gt;95 g/m2 in females was used to define high LVMI, and &gt;0.42 was used to define high RWT. Patients with more than mild concomitant aortic stenosis were excluded. The study outcome was all-cause mortality. Results A total of 1538 patients were included, of which 362 (23.5%) had normal LV geometry (NG), 774 (50.3%) had eccentric hypertrophy (EH), 286 (18.6%) had concentric hypertrophy (CH), and 116 (7.5%) had concentric remodeling (Fig 1-a). Compared to the NG group (Fig 2), the EH group had more females, with larger LV size and left atrial volume index (LAVI). Compared to the NG group, patients in the CH group were significantly older and had more proportion of females. Moreover, they were more symptomatic, had higher prevalence of arterial hypertension, atrial fibrillation, and worse renal function, with smaller LV end-diastolic diameters and thicker LV walls.. Compared to the NG group, the CR group included patients with significantly smaller LV cavities and thicker LV walls, but interestingly similar LAVI and systolic pulmonary pressure, suggesting that this group might represent patients with a rather acute onset MR. Of note, there was no difference among the groups as regards LV systolic dysfunction (ejection fraction ≤ 60%, P=0.314). However, patients with CH and CR had significantly worse e’ and E/e’ ratio. After a median follow-up of 6.2 years, 211 (13.7%) patients died. Kaplan-Meier analysis showed similar survival between the NG and EH groups (91.4 vs 91.6%, P = 0.964), with significantly lower survival in the CH (76.6%, P&lt;0.001) and CR (81.9%, P=0.028) groups, compared to NG (Fig 1-b). On multivariable analysis, after correcting for all the significant variables (Fig 1-c), CH and CR patterns carried higher risk of mortality (HR 1.7, P=0.024 and 2.0, P=0.017) compared to NG, while EH carried no additional risk (P=0.768). Conclusion LV remodeling patterns help in phenotyping patients with PMR undergoing MV surgery, and are independently associated with different risks of post-operative mortality.Figure 1:Prevalence and outcome Figure 2:Baseline characteristics
BAK and BAX: Therapeutic Targets for Acute Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury
Xu, Zejun, Meng, Fei , Yang, Hongjun, Ye, Kaiqin, Qin, Fei, Liu, Dongyan, Dai, Haiming , Ye, Kaiqin , Dai, Haiming , Yang, Hongjun, Liu, Ying

Mayo Clinic

Biology | December 31, 2025 | Volume: 15 | Issue: 1 | Pages: 81

10.3390/biology15010081 | PMID 41514922 Get It

Acute myocardial infarction (AMI) is a significant factor leading to the death of patients with coronary heart disease. Both AMI and reperfusion therapy after AMI cause myocardial cell death, which plays a significant role in heart failure. Following the restoration of blood flow during reperfusion, myocardial cells generate a large amount of oxygen free radicals, causing various forms of myocardial ischemia–reperfusion (IR) injury (IRI), ultimately leading to multiple types of myocardial cell death, among which apoptosis and necroptosis are the two major types. Given the extremely limited regenerative capacity of myocardium, inhibiting myocardial cell apoptosis and necroptosis is a key strategy for reducing mortality in patients with AMI. Both apoptosis and necroptosis are regulated by the BCL2 family of proteins, which were modulated by multiple signaling pathways, converging at BAK/BAX-mediated mitochondrial outer membrane permeabilization (MOMP), as well as mitochondrial inner membrane permeabilization (MIMP). BAK/BAX double knock out (DKO) mice showed reduced cell apoptosis, necroptosis, and infarct size in AMI animal models compared to wild type. This review describes the role of BCL2 family proteins in regulating apoptotic and necroptotic myocardial cell death during AMI and IR, explores the upstream pathways modulating apoptosis and necroptosis, and summarizes the recent advances in targeting BAK and/or BAX for cardiac protection. In addition, targeted delivery of BAK/BAX inhibitors to cardiomyocytes during AMI or myocardial IR has the potential to reduce myocardial cell death and therefore lower the mortality and enhance long-term prognosis for myocardial infarction patients.
Ventricular arrhythmias during exercise in patients with mitral valve prolapse
Wijngaarden, Aniek L. van , Riva, Marta , El‐Am, Edward , Michelena, Héctor I. , Rahme, Serena, Enriquez‐Sarano, Maurice , van Wijngaarden, Aniek , Michelena, Hector I , Rahme, Serena J, Medina Inojosa, Jose, Enriquez-Sarano, Maurice , Marsan, Nina Ajmone , Sabbag, Avi , Essayagh, Benjamin , Medina‐Inojosa, José R. , Bax, Jeroen J. , Marsan, Nina Ajmone

Mayo Clinic

Heart | October 20, 2025 | Volume: 112 | Issue: 14 | Pages: 781-788

10.1136/heartjnl-2025-326395 | PMID 41115769 Get It

Background Mitral valve prolapse (MVP) can be associated with ventricular arrhythmias (VA), but little is known about the relationship between VA and exercise in these patients. The aim of this study was to assess the occurrence and severity of VA during exercise tests in patients with MVP, and to explore the association between VA during exercise and the occurrence of arrhythmic events during follow-up. Methods In this multicentre study, 375 patients with MVP (58 (48–69) years, 53% male) who underwent a clinically indicated exercise test were included. Severity of VA during exercise was defined as: (1) no VA, (2) minor VA (premature ventricular contractions ≥5% or non-sustained ventricular tachycardia (nsVT) <120 beats per minute) and (3) major VA (nsVTs ≥120 beats per minute). Results During exercise test, 242 (65%) patients showed no VA, 88 (24%) minor VA and 45 (12%) major VA. Patients with minor and major VAs showed more often bileaflet prolapse and mitral annular disjunction (MAD) than patients with no VA (p<0.001). Over a median follow-up of 101 months (IQR 58–138 months), 35 patients (9%) developed a severe arrhythmic event, defined as sustained VA or ventricular fibrillation, implantation of an implantable cardioverter-defibrillator and VA ablation. At the Kaplan-Meier curve analysis, patients with major VA showed the worst arrhythmic event-free survival (log-rank p<0.001). On multivariable analysis, left ventricular end-systolic diameter, MAD and VA severity during exercise were independently associated with this outcome. Conclusions In patients with MVP, the occurrence of VA during exercise is associated with more advanced mitral valve abnormalities, including MAD, and with higher rates of severe arrhythmic events during follow-up. Performing an exercise test, combined with the clinical and echocardiographic assessments, may therefore offer important complementary information useful for patient management.
Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY
Dannenberg, Varius , Topilsky, Yan , Benfari, Giovanni , Weber, Marcel, Eixerés‐Esteve, Andrea , Bazire, Baptiste , Iung, Bernard , Riant, Elisabeth , Habib, G., Hausleiter, Jörg , Stolz, Lukas , Badano, Luigi P. , Tourneau, Thierry Le, Zamorano, José Luis , Fam, Neil , Sievert, Horst, Heuts, Samuel , Nejjari, Mohammed, Bonis, Michele De , Rudolph, Volker , Lurz, Philipp, Bax, Jeroen J., Gauda, Roja, Bernick, Jordan , Wells, George A. , Maisano, Francesco, Bartko, Philipp E. , Investigators, for the TRIGISTRY, Messika-Zeitoun, David , Enriquez-Sarano, Maurice , Benfari, Giovanni , Hausleiter, Jörg , De Bonis, Michele , Heitzinger, Gregor , Dreyfus, Julien , Marsan, Nina Ajmone , Taramasso, Maurizio , Russo, Giulio , Bohbot, Yohann , Iliadis, Christos , Weber, Marcel , Nombela‐Franco, Luis , Obadia, Jean‐François , Estévez‐Loureiro, Rodrigo , Donal, Erwan , Lavie-Badie, Yoan , Tourneau, Thierry Le, Coisne, Augustin , Modine, Thomas , Praz, Fabien , von Bardeleben, Ralph Stephan , Hahn, Rebecca T , Muraru, Denisa , Adamo, Marianna , Nejjari, Mohammed , Chan, Vincent, Carnero, Manuel , Crestanello, Juan A. , Maisano, Francesco , Enriquez‐Sarano, Maurice , Messika–Zeitoun, David , Investigators, for the TRIGISTRY

Mayo Clinic

European Journal of Heart Failure | August 31, 2025 | Volume: 27 | Issue: 11 | Pages: 2634-2643

10.1002/ejhf.3797 | PMID 40886066 Get It

ABSTRACT Aims The impact of treatment for tricuspid regurgitation (TR) across different levels of left ventricular ejection fraction (LVEF) remains uncertain. This study aimed to compare the outcomes of surgical and transcatheter tricuspid valve interventions (TTVI) to conservative (medical) management across LVEF categories. Methods and results Patients with severe isolated TR from the TRIGISTRY, a multicentre international registry, were categorized based on LVEF (preserved ejection fraction [pEF]: ≥50%, mildly reduced ejection fraction [mrEF]: 41–49%, and reduced ejection fraction [rEF]: ≤40%). We assessed the impact of treatment modality and procedural success (mild-to-moderate or lower residual TR) on 2-year survival within each LVEF category. Among 2384 patients, 1383 had pEF, 400 had mrEF, and 601 had rEF. Compared to conservative management, surgery (p &lt; 0.0005) and TTVI (p &lt; 0.0001) were associated with a survival benefit in patients with pEF. No significant survival advantage was observed in patients with mrEF (p = 0.28 for both), nor in those with rEF (p = 0.76 and p = 0.22, respectively). Similar results were obtained when surgical and transcatheter interventions were grouped (p &lt; 0.0001, p = 0.17 and p = 0.29 in patients with pEF, mrEF and rEF, respectively). Patients with residual TR after TTVI exhibited a trend toward worse survival compared to those managed conservatively across all LVEF categories (p = 0.47, p = 0.33 and p = 0.008 in pEF, mrEF and rEF, respectively). Conclusions Transcatheter tricuspid valve intervention, whether surgical or transcatheter-based, was associated with improved survival in patients with pEF but not in those with mrEF or rEF. Residual TR remained a significant prognostic factor across the entire LVEF spectrum. These findings highlight the need for careful patient selection when considering TTVI in individuals with rEF.
Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse: Prevalence, Predictors, and Association With Outcomes
Topilsky, Yan , Essayagh, Benjamin , Benfari, Giovanni , Tourneau, Thierry Le , Antoine, Clémence , Grigioni, Francesco , Roussel, Jean‐Christian , Bax, Jeroen J. , Wijngaarden, Aniek L. van , Tribouilloy, Christophe , Loewenstein, Itamar , Thapa, Prabin , Le Tourneau, Thierry , Marsan, Nina Ajmone , van Wijngaarden, Aniek , Tribouilloy, Christophe , Hochstadt, Aviram , Thapa, Prabin , Michelena, Hector I , Enriquez-Sarano, Maurice , Bax, Jeroen J , Benfari, Giovanni , Essayagh, Benjamin , Grigioni, Francesco , Marsan, Nina Ajmone , Michelena, Héctor I. , Enriquez‐Sarano, Maurice

Mayo Clinic

Journal of the American Heart Association | July 17, 2025 | Volume: 14 | Issue: 15 | Pages: No page available

10.1161/jaha.124.040868 | PMID 40673524 Get It

Background Left ventricular (LV) end‐systolic enlargement in severe degenerative mitral‐regurgitation (MR) is a class I surgical trigger. Whether it occurs disproportionately to less‐than‐severe MR due to mitral valve prolapse and is associated with mortality are unknown. We aimed to analyze prevalence and association with survival of disproportionate LV enlargement in less‐than‐severe MR. Methods A multicenter cohort international study enrolled 2848 consecutive patients (52% women, 69±16 years) with degenerative MR prospectively quantified and graded mild or moderate. Primary end point was survival under medical management. Secondary outcome was survival throughout follow‐up stratified by performance of early mitral surgery within 3 months postdiagnosis. Results Among LV remodeling parameters (abnormal end‐diastolic diameter, LV end‐systolic diameter [LVESD] absolute and indexed), LVESD ≥40 mm (present in 12.4%) was the sole independent associate of reduced survival (5‐year 70±3 versus 76±9%; P =0.009). LVESD ≥40 mm was independently linked to larger body surface area, effective regurgitant orifice, and left atrium, and to male sex and diabetes. With multivariable comprehensive adjustment, LVESD ≥40 mm (adjusted hazard ratio [aHR], 1.25 [95% CI, 1.005–1.53]; P =0.04) remained associated with excess mortality under medical management, even after adjustment for lowered ejection fraction (aHR, 1.49 [95% CI, 1.13–1.95]; P =0.004) and in all patient subsets. Among patients with moderate degenerative MR and LVESD ≥40 mm, 22% underwent mitral surgery within 3 months, which was associated with superior survival, even after comprehensive adjustment (aHR, 0.11 [95% CI, 0.005–0.51]; P =0.002). Conclusions Disproportionate LV enlargement in patients with less‐than‐severe degenerative MR is common, particularly with larger bodies, regurgitation, and overall cardiac remodeling. LVESD ≥40 mm is associated with worse survival independent of all baseline characteristics, even lowered ejection fraction, and represents a marker for risk stratification of patients who are generally not yet considered for medical or surgical/interventional treatment.